Page last updated: 2024-11-07

prednisone and Atypical Hemolytic Uremic Syndrome

prednisone has been researched along with Atypical Hemolytic Uremic Syndrome in 4 studies

Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.

Atypical Hemolytic Uremic Syndrome: An hereditary hemolytic uremic syndrome associated with variations in the gene that encodes COMPLEMENT FACTOR H, or the related proteins CFHR1 and CFHR3. Disease often progresses to CHRONIC KIDNEY FAILURE without the prodromal symptoms of ENTEROCOLITIS and DIARRHEA that characterize typical hemolytic uremic syndrome.

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ankawi, GA1
Clark, WF1
Sana, G1
Dragon-Durey, MA1
Charbit, M1
Bouchireb, K1
Rousset-Rouvière, C1
Bérard, E1
Salomon, R1
Frémeaux-Bacchi, V1
Niaudet, P1
Boyer, O1
Verhave, JC1
Westra, D1
van Hamersvelt, HW1
van Helden, M1
van de Kar, NC1
Wetzels, JF1
De, S1
Waters, AM1
Segal, AO1
Trautmann, A1
Harvey, EA1
Licht, C1

Other Studies

4 other studies available for prednisone and Atypical Hemolytic Uremic Syndrome

ArticleYear
Atypical haemolytic uremic syndrome (aHUS) and membranoproliferative glomerulonephritis (MPGN), different diseases or a spectrum of complement-mediated glomerular diseases?
    BMJ case reports, 2017, Aug-10, Volume: 2017

    Topics: Administration, Oral; Adult; Antibodies, Monoclonal, Humanized; Atypical Hemolytic Uremic Syndrome;

2017
Long-term remission of atypical HUS with anti-factor H antibodies after cyclophosphamide pulses.
    Pediatric nephrology (Berlin, Germany), 2014, Volume: 29, Issue:1

    Topics: Anti-Inflammatory Agents; Atypical Hemolytic Uremic Syndrome; Autoantibodies; Autoantigens; Child; C

2014
Living kidney transplantation in adult patients with atypical haemolytic uraemic syndrome.
    The Netherlands journal of medicine, 2013, Volume: 71, Issue:7

    Topics: Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Atypical

2013
Severe atypical HUS caused by CFH S1191L--case presentation and review of treatment options.
    Pediatric nephrology (Berlin, Germany), 2010, Volume: 25, Issue:1

    Topics: Atypical Hemolytic Uremic Syndrome; Blood Component Transfusion; Combined Modality Therapy; Compleme

2010